N

Nektar Therapeutics
D

NKTR

0.90160
USD
0.01
(0.76%)
مغلق
حجم التداول
20,559
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
166,307,589
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    AZN
    AZN
    -0.290
    (-0.43%)
    66.620 USD
    BIIB
    BIIB
    -0.660
    (-0.47%)
    140.580 USD
    BMY
    BMY
    -0.100
    (-0.18%)
    56.300 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    I
    INCY
    -0.500
    (-0.69%)
    71.950 USD
    LLY
    LLY
    -32.08
    (-4.23%)
    726.07 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    المزيد
الأخبار
المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).